The Curexsys GmbH is a recently established, Goettingen, Germany-based technology leader specialising in the emerging field of therapeutic exosomes. These are small vesicles that are naturally released from cells and have immunomodulatory and anti-inflammatory effects, which makes them a promising novel approach for innovative regenerative therapies, as therapeutics in age-related conditions, but also for diagnostic purposes. Therapeutic exosomes hold significant promise for regenerative medicine and beyond.